EFPIA - NEWSLETTER

EFPIA Newsletter 13 January 2022

Safeguarding the supply of medicines to patients in Europe

"I am proud to say that despite an exponential increase in the demand for some medicines, the research-based pharmaceutical industry was able to increase capacity, in some cases by as much as 300-400 percent, and manage supply issues to the point that not a single EFPIA member reported disruption to supply of finished products during that extremely challenging period."

Lars Fruergaard Jørgensen, President and CEO at Novo Nordisk and First Vice-President at EFPIA, reflects on what Covid-19 thought us and what we can do to avoid shortages of medicines in the future.

News

13 January 2022 EFPIA statement on a GDPR Code of Conduct

A GDPR Code of conduct will enable the sector to align on key data protection positions, thereby providing more consistency,...

11 January 2022 Stronger Intellectual Property Rights in EU Free Trade Agreements can boost GDP, productivity,...

Discover a recent ECIPE report, supported by EFPIA among other industry associations.

06 January 2022 EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report

Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy...

04 January 2022 EFPIA Press Release welcoming the French Presidency of the Council of the EU

As the French Presidency of the Council begins, it is time for Europe to back innovation and boost access to medicines....

17 December 2021 Industry response to NI Protocol proposals

The European Commission and UK Government have taken significant practical steps towards resolving outstanding issues...

Events

24 JAN 2022

Supporting Pharma Innovation in Europe Virtual event

Presented by the FT, in partnership with EFPIA.

Learn more →

26 JAN 2022

Introducing the Innovative Health Initiative: Europe’s new partnership for health... Virtual event

Registration is now open!

Learn more →

What we are reading

Innovation and access: Improving Europe’s pharmaceutical regulatory framework 13 January 2022 (pharmaphorum.com)

Leaders of change: does it take a patient to put patients first? 01 January 2022 (The Lancet)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶